NCT05360576View on ClinicalTrials.gov

An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study

PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

February 24, 2022

Primary Completion Date

July 4, 2022

Study Completion Date

July 4, 2022

Conditions

Pregnancy Prevention

Interventions

DRUG

LSP-5415 (etonogestrel/ethinyl estradiol vaginal ring)

To prevent pregnancy

DRUG

NuvaRing Vaginal Ring

To prevent pregnancy

Trial Locations (1)

40710

Site 01, Mohope

Sponsors

Lead Sponsor

Lupin Research Inc

All Listed Sponsors

lead

Lupin Research Inc

INDUSTRY

NCT05360576 - An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study | Biotech Hunter | Biotech Hunter